Skip to contentApplication 761137
- Type
- BLA
- Sponsor
- ASTELLAS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PADCEV | ENFORTUMAB VEDOTIN-EJFV | INJECTABLE;INJECTION | 20MG/VIAL | No | No |
| 002 | PADCEV | ENFORTUMAB VEDOTIN-EJFV | INJECTABLE;INJECTION | 30MG/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |